Cancer Research UK estimates that 3 million fewer people were screened for cancer between March and September last year, meaning around 9,200 fewer patients started cancer treatment as a result in England alone – a 42% drop.
Disruption to cancer screening, diagnosis and treatment has led to more than 45,000 fewer people starting cancer treatment between March 2020 and March 2021.
We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.
We caught up with people living with cancer across the country, to find out how the coronavirus pandemic has been affecting them and their families.
We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.
There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.
More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.
COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.
2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers.